Acute Kidney Injury Classification Underestimates Long-Term Mortality After Cardiac Valve Operations.

Acute Kidney Injury Classification Underestimates Long-Term Mortality After Cardiac Valve Operations.

Click the title to purchase the article.

Background: "Perioperative acute kidney injury (AKI) is an important predictor of long-term all-cause mortality after coronary artery bypass (CABG). However, the effect of AKI on long-term mortality after cardiac valve operations is hitherto undocumented."1


 

1. Acute Kidney Injury Classification Underestimates Long-Term Mortality After Cardiac Valve Operations.
Bouma HR, Mungroop HE, de Geus AF, Huisman DD, Nijsten MWN et al.
Ann Thorac Surg. 2018 Jul;106(1):92-98

 

Recent Stories
FREE: The Case for the Anesthesiologist-Informaticist.

FREE: Robotic Cardiac Surgery in Europe: Status 2020.

FREE: Efficacy of Prothrombin Complex Concentrate (PCC) versus Fresh Frozen Plasma (FFP) in Reducing Perioperative Blood Loss in Cardiac Surgery: Study Protocol for A Non-Inferiority, Randomised Controlled Trial.

AmSECT Membership Eligibility

An Active Member shall be any perfusionist active in the practice of extracorporeal circulation technology. There are also opportunities to become a Transitional Active Member for those less than a year removed from graduation from an approved accredited training program. Other options include; an Associate Membership, International Membership, Perioperative Blood Management Clinician Membership, and Student Membership.

Click Here to Learn More

Looking for Employment Opportunities?

AmSECT members may post an available position for a perfusion specialty at your institution or firm.

Non-members may also post positions free of charge, to be reviewed by National Headquarters prior to posting.

Members - Click to Post a Position
Non-Members - Click to Post a Position

Contact AmSECT


AmSECT National Headquarters
330 N Wabash Ave, Suite 2000
Chicago, IL 60611

  Phone: (312) 321-5156
  Fax: (312) 673-6656
  Email: amsect@amsect.org

AmSECT © 2022 | View Privacy Policy | Site Map